Upinder Singh
Infectious Disease · Iowa City, IANPI 1457487613
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,362 of the $8,362 with a category attached, or 100.0%. Gilead accounts for 73.1% of it on its own, with 1 other manufacturer making up the rest. Among infectious disease clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 9 payments — averaging $929.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$6K
- Regeneron$2K
Across 97 payments — averaging $67,134 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4.2M
- Regeneron$2.3M
What the payments were for
- Consulting fees$8,362100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veklury$6,112
How this compares
$8,362 in reported general payments places this provider in the 90th percentile of 58 infectious disease providers in Iowa.
Other infectious disease in Iowa City
- Michael OhlIowa City$9K
- Karen BrustIowa City$4K
- Patricia WinokurIowa City$3K
- Yacoub SallamIowa City$631
- Lemuel Benedict NonIowa City$619
- David KusnerIowa City$207
- Eric DahlquistIowa City$125
- Jacob HodgesIowa City$84
- Dilek InceIowa City$36
- Quanhathai KaewpoowatIowa City$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.